Parkinson’s disease

The interdisciplinary team identifies potential gut microbiome origins of disorder

Brain molecule reverses movement deficits of Parkinson’s, offering new therapeutic target

UCI has launched a Center for Neurotherapeutics to facilitate drug discovery for neurological diseases. It’s led by Dr. Albert LaSpada, Distinguished Professor of pathology, neurology and biological chemistry, as well as associate dean for research development at the UCI School of Medicine; and Robert Spitale, professor and associate dean of research at the UCI School […]

L-dopa-protein complex may cause cellular iron overload in brain, leading to side effects